Immune Pharmaceuticals Signs License & Research Agreement for AmiKet Nano

By: via Benzinga
Immune Pharmaceuticals Inc. (NASDAQ: IMNP) announced today that it has entered into a definitive license and research agreement with ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.